Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5289896 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5299076 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5285386 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5292827 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5294672 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL899023 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5291307 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5289929 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL5300886 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 | |
| SCHEMBL898650 | 1.00 | TSHR (0.42) | TSHRTHRBGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20090242414-A1 | ELECTRONCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-10-01 | — | — | US | claimed |
| EP-1951934-B1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-08-19 | — | — | EP | claimed |
| US-20080210566-A1 | Electrochemical Deposition of Selenium in Ionic Liquids | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-04 | — | — | US | claimed |
| EP-1951934-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2008-08-06 | — | — | EP | claimed |
| EP-1831433-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2007-09-12 | — | — | EP | claimed |
| WO-2007039035-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2006061081-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2006-06-15 | — | — | WO | claimed |
| US-12002631-B2 | Electrodeposited dielectric for a solid electrolytic capacitor | KYOCERA AVX Components Corporation (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230118528-A1 | Electrodeposited Dielectric for a Solid Electrolytic Capacitor | KYOCERA AVX Components Corporation | 2023-04-20 | — | — | US | disclosed |
| US-RE48165-E1 | Alkenyl (perfluoroalkyl) phosphinic acids | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | MERCK PATENT GMBH (DE) | 2018-12-25 | — | — | US | disclosed |
| EP-3207047-B1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | MERCK PATENT GMBH (DE) | 2018-09-12 | — | — | EP | disclosed |
| EP-1831433-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2007-09-12 | — | — | EP | disclosed |
| WO-2007039035-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| WO-2006061081-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2006-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | PHOSPHO1, PFAS, SLCO4C1 | TSHR 1864/4885THRB 3203/4885GNAI3 1928/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | TSHR 3199/4885THRB 3886/4885GNAI3 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.